ADXN: addextherapeutics.com Company Total Sales
Scientific confidence in the allosteric modulator platform of Addex Therapeutics (ADXN) is bolstered by the creation of a closed ecosystem for precision CNS therapy. The volatility of the company's sales visualizes current activity, where the 0.00 mark indicates the level of the business's operational resilience. A steady influx of partner capital from pharma behemoths and management's expertise in developing neuro-drugs provide the company with long-term growth potential.
Comprehensive metric breakdowns and analytics for Addex Therapeutics Ltd (ADXN)
- share price and expert price forecast:
- market capitalization information:
- book capitalization indicators:
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Addex Therapeutics|ADXN - Long-Term Debt to Capital|Short-Term Debt to Capital Addex Therapeutics Ltd.|ADXN - Company Debts|Debts to Book Capitalization Ratio Addex Therapeutics Ltd|ADXN - Company Long-Term Debts|Short-Term Debt Addex Therapeutics|Quick Ratio addextherapeutics.com
- earnings and valuation multiples indicators:
ADXN - Net Income|Future Net Profit Addex Therapeutics|ADXN - P/E Multiple|Market Cap to Projected Earnings addextherapeutics.com|ADXN - PEG Multiple|Enterprise Value to EBITDA Ratio Addex Therapeutics Ltd|ADXN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Addex Therapeutics|ADXN - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth addextherapeutics.com|ADXN - Earnings growth in current year|Projected earnings per share growth rate for next year Addex Therapeutics
- company sales and revenue statistics:
Comprehensive company analysis:Addex (ADXN)
A comparative asset analysis requires evaluating current revenue against historical values to determine real consumer demand amid inflationary pressures. This metric measures cash flow intensity, which is critical for Addex Therapeutics (ADXN) due to its reliance on pharma partner payments and risks associated with neurological research, reflecting the stability of the company's product sales revenue.
Key competitors
BIIB: Company Sales Revenue|Company Sales NBIX (Neurocrine Biosciences)|Company Total Sales RGC|Revenue and Sales Volume AXSM (Axsome Therapeutics, Inc.)|Company Sales Revenue ACAD|Xenon Pharmaceuticals Inc - Revenue and Sales Volume|Company Total Revenue Viking Therapeutics Corp|Supernus Pharmaceuticals (SUPN) - Company Revenue|catalystpharma.com - Company Sales Revenue|DNLI (Denali Therapeutics Inc.) - Revenue and Sales Volume|Revenue and Sales Volume Harmony Biosciences Inc|Company Revenue Biohaven Pharmaceutical (BHVN)|AMLX: Company Annual Revenue|Revenue and Sales Volume TRVI (Trevi Therapeutics)|praxismedicines.com (PRAX) - Company Total Revenue|AVXL: Company Sales|CBLL - Revenue and Sales Volume|PRTA (Prothena Corporation PLC) - Company Sales|ALEC: Company Total Sales|ANNX (Annexon, Inc.) - Revenue and Sales Volume|Omeros Corp. (OMER) - Company Gross Revenue|Revenue and Sales Volume NGNE|Company Sales AC Immune S.A. ACIU|Company Revenue Voyager Pharma VYGR|Company Gross Revenue Neumora Corp (NMRA)|Scilex Holding Company - Revenue and Sales Volume|TVGN - Revenue and Sales Volume|ACOG: Revenue and Sales Volume|Company Sales Volume CGTX|Company Sales IKT|Company Sales Volume SAVA (Cassava Pharma)|Company Revenue Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Company Sales Volume|Company Revenue Vistagen VTGN|OVID: Company Sales Volume|Acumen Pharma - Revenue and Sales Volume|Company Total Revenue CervoMed Corporation|ATHE (alteritytherapeutics.com) - Company Sales|Clene (CLNN) - Revenue and Sales Volume|Company Revenue PepGen Inc|JUNS: Company Sales Revenue|Company Revenue Relmada (RLMD)|ANVS - Company Total Revenue|Revenue and Sales Volume GRCE (Grace Therapeutics)|Revenue and Sales Volume fireflyneuro.com AIFF|ANEW Medical, Inc. - Revenue and Sales Volume|NRSN (NeuroSense Therapeutics) - Company Sales Volume|RVPH: Revenue and Sales Volume|Company Sales Volume MTVA|NRXS (NeurAxis, Inc.) - Revenue and Sales Volume|Company Total Revenue Helius Medical Technologies Inc. HSDT|Company Sales PASG (Passage Bio, Inc.)|bionomics.com.au - Company Sales Volume|Minerva Neurosciences Corp - Company Sales|Company Sales Revenue ATHA|ALZN: Company Sales|Cyclerion Therapeutics - Company Total Sales|PTIX: Revenue and Sales Volume|Pasithea Therapeutics Corp. - Company Sales Revenue|CRGT (Cortigent Inc) - Revenue and Sales Volume|Company Total Revenue Avenue Therapeutics Inc ATXI|Company Revenue Brainstorm Cell (BCLI)|CARA (caratherapeutics.com) - Company Sales Revenue|Revenue and Sales Volume CHRO (Chromocell Therapeutics Corp.)|Revenue and Sales Volume Eliem Therapeutics, Inc. ELYM|ITCI - Company Revenue|Company Annual Revenue LBPH|MRNS: Revenue and Sales Volume|Company Total Revenue nkgenbiotech.com (NKGN)|Company Sales NRBO|Revenue and Sales Volume Sage Therapeutics Inc.|Company Sales SNPX (Neurotrope)|Company Total Sales TRVN|Revenue and Sales Volume VIGL (Vigil Neuroscience, Inc.)|Company Gross Revenue Anew Medical Inc. (WENA)|Cerevel Therapeutics, Inc. - Revenue and Sales Volume
